OTOH, it's a problem if people are basing real-world decisions on stuff that hasn't reached textbook level certainty. That's pretty much what happened with dietary advice and sugars. "Two scratchpads say a high-carb low-fat diet is good? Okay, then plaster it all over the public schools."
For a recent personal example, a company published a paper saying that if you give a pre-treat with 2 doses of a particular drug, you can avoid some genetic markers of inflammation that are in the bloodstream and kidneys. Well, I looked at the stimulus and ordered some of my own from a different manufacturer that was easier to obtain and gave it to some mice with and without pretreatment by their compound. Instead of looking at the genes they looked at, I looked at an uptick in a protein expected to be one step removed from the genes they showed a change in. Well I haven't exactly replicated their study, but I've replicated the core points: stimulus with a the same cytokine gives a response in a particular pathway and it either is or isn't mitigated by the drug or class of drugs they showed. Now, my study took 2 days less than theirs, but it worked well enough that I don't need to fret the particular details I did differently from them. If my study didn't work, I could either decide that the study isn't important to me if it didn't work my way or go back a step and try to match their exact reagents and methods.
So yes, I do think the news industry picks up stuff too quickly sometimes, but depending on the outlet, they tend to couch things in appropriate wiggle words (may show, might prove, could lead to, add evidence, etc).
It's like the stages of clinical research - there we have general standards on when it is considered acceptable to use findings for actually treating people (e.g. phase 3 studies), but it's obviously clear that we need to publish and discuss the initial findings since that's required to actually get to the phase 3 studies. However, the effects seen in phase 1 studies often won't generalize to something that actually works in clinical practice, so if general public reads them then often they'll assume predictions that won't come true.
E.g., looking from the perspective of a scientist-reader, if someone has spent a few months doing the ad hoc hands on experiments and achieved interesting observations, then I would want them to publish that research now, instead of spending another half a year to make the repeatable procedure or possibly not publishing it ever because they'd rather do something else than make it up to these standards. There is a benefit from getting all the tricks to make the experiment cleaner, but the clean experiment is just means for acquiring knowledge and ideas for further research, not an end goal by itself for a researcher in that area. Outsiders may have different interests though (https://news.ycombinator.com/item?id=13716233 goes into detail) preferring "finalized and finished research" but to the actual community (who in the end is doing everything and evaluating/judging their peers) generally would prefer the work in progress to be published as-is instead of having more thorough results, but later and less of them.
Outsiders can get the repeatable procedures when it's literally textbook knowledge, packaged in assignments that can be given to students for lab exercises (since that's the level what truly repeatable procedures would require). Insiders want the bleeding edge results now, so they design their journals and conferences to exchange that.